Sri Lanka vs Uganda: Hepatitis B surface antigen (HBsAg) prevalence
Sri Lanka
0.3%
in 2024
Uganda
0.3%
in 2024
Sri Lanka rank
71st
Uganda rank
71st
Hepatitis B surface antigen (HBsAg) prevalence over time
- Sri Lanka
- Uganda
How they compare
Sri Lanka currently reports 0.3% against 0.3% in Uganda, a difference of 0.0%.
Across all 10 years both countries report, Uganda has been ahead every year.
Sri Lanka ranks 71st and Uganda ranks 71st of 194 countries.
Uganda has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Sri Lanka | Uganda | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.4% | 0.1% | Uganda |
| 2020s | 0.3% | 0.4% | 0.1% | Uganda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Sri Lanka or Uganda?
- Sri Lanka, at 0.3% against 0.3% in Uganda as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Sri Lanka and Uganda?
- 0.0%, with Sri Lanka ahead.
- How many years of comparable data are there for Sri Lanka and Uganda?
- 10 years are reported by both, from 2015 to 2024.
- How do Sri Lanka and Uganda rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Sri Lanka ranks 71st and Uganda ranks 71st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.